anonymous
Guest
anonymous
Guest
Novartis' knockoff of Biogen's Tysabri is first MS biosim in US
Novartis wins FDA nod for first biosimilar version of Biogen's MS blockbuster Tysabri
Novartis wins FDA nod for first biosimilar version of Biogen's MS blockbuster Tysabri